Cell Therapy in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Cell Therapy Market Research Report | Life Sciences | Blood & Organ Banks | May 2013

Generating Growth: More funding for R&D will help maintain strong revenue gains

IBISWorld’s Cell Therapy market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Market Share of Companies
Dendreon Dendreon market share
NuVasive NuVasive market share
Organogenesis Organogenesis market share
Shire Pharmaceuticals Shire Pharmaceuticals market share
Industry Statistics & Market Size
Annual Growth 08-13
Annual Growth 13-18
Purchase to read more
Purchase to read more
Industry Analysis & Industry Trends

The Cell Therapy industry is a fast-growing industry. The demand for the industry's products and services depends primarily on the level of investment in medical technology. Strong growth will slow slightly over the five years to 2018, but it will still outpace a majority of the economy.... purchase to read more

Industry Report - Industry SWOT Analysis Chapter

The Cell Therapy industry is in the growth phase of its economic life cycle. During the 10 years to 2018, IBISWorld estimates industry value added (IVA), a measure of the industry's contribution to the US economy, is expected to greatly outpace US GDP. IVA is projected to grow at an annualized 14.2% during this period, while IBISWorld forecasts US GDP to expand at an average annual 2.1% during the same period.

While some cell therapy has been around for decades, a rapid increase in research and development over the past decade has changed the industry's growth trajectory. The FDA approved no new products from 2002 to 2008 but half a dozen products have since been approved... purchase to read more


Industry ProductsRelated ReportsTable of Contents

What is the Cell Therapy Industry?

This industry engineers human tissue, also known as cell therapy or regenerative medicine. Tissue engineering is the use of a combination of cells, engineering and materials methods, and suitable biochemical and chemical factors to improve or replace biological functions. Key functions include repairing or replacing tissues (e.g. bone, cartilage, blood vessels and skin)

Industry Products
Skin and chronic wound cell therapy productsMusculoskeletal cell therapy productsCancer cell therapy products
Industry Activities
Development and skin and chronic wound cell therapy productsDevelopment and musculoskeletal cell therapy productsDevelopment and cancer cell therapy productsDevelopment and other cell therapy products

View Sample
Select Clients